The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties
- 14 May 2008
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 14 (2), 95-106
- https://doi.org/10.1111/j.1527-3458.2008.00043.x
Abstract
Propofol (2,6-diisopropylphenol) is a versatile, short-acting, intravenous (i.v.) sedative-hypnotic agent initially marketed as an anesthetic, and now also widely used for the sedation of patients in the intensive care unit (ICU). At the room temperature propofol is an oil and is insoluble in water. It has a remarkable safety profile. Its most common side effects are dose-dependent hypotension and cardiorespiratory depression. Propofol is a global central nervous system (CNS) depressant. It activates gamma-aminobutyric acid (GABA A) receptors directly, inhibits the N-methyl-d-aspartate (NMDA) receptor and modulates calcium influx through slow calcium-ion channels. Furthermore, at doses that do not produce sedation, propofol has an anxiolytic effect. It has also immunomodulatory activity, and may, therefore, diminish the systemic inflammatory response believed to be responsible for organ dysfunction. Propofol has been reported to have neuroprotective effects. It reduces cerebral blood flow and intracranial pressure (ICP), is a potent antioxidant, and has anti-inflammatory properties. Laboratory investigations revealed that it might also protect brain from ischemic injury. Propofol formulations contain either disodium edetate (EDTA) or sodium metabisulfite, which have antibacterial and antifungal properties. EDTA is also a chelator of divalent ions such as calcium, magnesium, and zinc. Recently, EDTA has been reported to exert a neuroprotective effect itself by chelating surplus intracerebral zinc in an ischemia model. This article reviews the neuroprotective effects of propofol and its mechanism of action.Keywords
This publication has 84 references indexed in Scilit:
- Neuroprotective effects of anesthetic agentsJournal of Anesthesia, 2005
- Zinc inhibits glutamate release via activation of pre‐synaptic KATP channels and reduces ischaemic damage in rat hippocampusJournal of Neurochemistry, 2004
- The anaesthetic agent propofol interacts with GABAB-receptors: an electrophysiological study in ratLife Sciences, 2003
- Neuroprotective effects of propofol following global cerebral ischemia in ratsNeurosurgical Review, 2002
- Effect of 2,6-Diisopropylphenol on the delayed hippocampal cell loss following transient forebrain ischemia in the gerbilLife Sciences, 1996
- PropofolDrugs, 1995
- Hyperalgesia during sedation: effects of barbiturates and propofol in the ratCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1995
- Effects of the general anaesthetic Propofol on the Ca2+‐induced permeabilization of rat liver mitochondriaFEBS Letters, 1991
- PropofolDrugs, 1988
- Propofol for intravenous sedationAnaesthesia, 1987